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Abstract
The objective of this study was to design citrate-coated gold nanoparticles conjugated
with FITC-IgG, a fluorescent antibody, and to qualitatively and quantitatively measure the
resulting fluorescent emission. Optical properties of the gold nanoparticles were measured at
various stages to provide evidence of successful conjugation. The absorbance spectrum of the
citrate gold nanoparticles was compared to that of the reaction mixture containing the gold
nanoparticles and the FITC-IgG. A noticeable broadening of the absorption peak was observed at
519 nm indicating a surface modification of the gold nanoparticles. Fluorescence data was
obtained with a fluorospectrometer and revealed a significant amount of fluorescent quenching in
the reaction mixture as well as the washed mixture containing only fully conjugated molecules.
However, the conjugated nanoparticles still emitted fluorescence at 519 nm as shown by the
images captured under confocal microscopy. Based on the obtained optical densities of the
reaction mixture and the FITC-IgG, the mass of molecules that were conjugated to the
nanoparticles was calculated and determined to be approximately 24 FITC-IgG molecules per
gold nanoparticle.
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Introduction
Nanotechnology is an applied science involving particles on the scale of 1-100 nm in
diameter. Advancements in the field of nanotechnology have proven to be applicable in the fields
of computer engineering, physics, and of particular interest medicine. In 2007, nearly $60 billion
worth of nanotechnology-based products were sold3. Currently in 2016, these figures have
exceeded $1 trillion. However, at this stage nanotechnology is still in its infancy as its potential
exceeds its products.
Nanomedicine has become one of the main fields of research involving nanotechnology.
It has the potential to develop new methods of diagnosing, preventing and treating various
diseases. Many of these applications stem from the fact that nanoparticles such as those made of
silver (Ag) and gold (Au) are unique due to their size on the nanoscale. Electrons in the
conduction band tend to oscillate at some extinction peak when light of a wavelength comparable
in size to the nanoparticle is incident as shown in Figure 1. This is called localized surface
plasmon resonance (LSPR). As a result of the LSPR phenomenon, a resonant field surrounds the
nanoparticle getting stronger as the distance from the surface decreases. Thus, being smaller than
the wavelength of light allows nanoparticles to exhibit unique physical and optical properties.4

Figure 1: Localized surface plasmon produced by interaction between the free electrons in the particles and an incident
electromagnetic wave. [9]

Gold nanoparticles have several properties that make them promising agents for stem cell
labeling and tracking. They are easy to manufacture and conjugate to a wide variety of
biomolecular targets5. Furthermore, In vitro studies have shown that mesenchymal and adiposederived stem cells labeled with gold nanoparticles did not demonstrate changes in cell function
or proliferation, and no toxicity was apparent. The binding of gold nanoparticles to stem cells
requires the expression of an antibody specific to a protein that is characterized on the surface of
the stem cell of interest. This can be accomplished by conjugating antibodies to gold
3

nanoparticles through various binding mechanism. The nanoparticle is first coated with citrate, a
stabilizing agent. This negatively charged coating prevents the nanoparticles from aggregating in
solution. The first binding mechanism is via hydrophobic interactions. Hydrophobic parts of the
antibodies become attracted to the surface of the nanoparticle forming a non-covalent bond. The
second binding mechanism is through electrostatic interactions of positively charged amino acids
on the antibodies and the negatively charged citrate coating. The last mechanism is through
covalent bonds between the nanoparticle and free sulfhydryl groups of the antibody. As a result,
controlling the directionality of the antibodies would require new conditions for binding. The
mechanisms described are shown respectively in the schematic in Figure 211.

Figure 2. A Schematic diagram of possible orientations of antibodies on AuNPs.

Once bound, nanoparticles can be further engineered for potential use as a stem cell
delivery system to areas of the body that require cell/tissue regeneration. One such application is
in the regeneration of ischemic cardiac tissue after an acute myocardial infarction (AMI). In the
United States, cardiovascular disease is the leading cause of death in the United Sates, claiming
more lives than all forms of cancer combined1. Of the various forms of heart disease, coronary
artery disease (CAD) is the most common, eventually leading to AMI. Every year approximately
735,000 Americans suffer from AMI1. Atherosclerosis, the buildup of plaque (fat, cholesterol,
and other substances) in the coronary arteries, causes the blood vessels to narrow and ultimately
restricts the flow of blood to the myocardium.
As blood flow is interrupted in an AMI, cardiomyocytes begin to die because they are
unable to obtain oxygen and the necessary nutrients for survival. This condition is known as
myocardial ischemia. If the adequate blood is not quickly restored, the surrounding cardiac tissue
undergoes apoptosis or necrosis. Human cardiomyocytes have a very limited ability to
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regenerate, thus as the heart begins to remodel after ischemia, the cardiac muscle tissue is
irreversibly replaced by fibrotic collagen scar tissue. The scar tissue therefore disrupts proper
contractile function resulting in decreased cardiac performance, ventricular dilation, and wall
thinning. This process of remodeling continues until the fibrotic scar’s tensile strength balances
the distending forces of the heart3. The ischemic tissue lacks function during systole, therefore
unable to contract of contribute to pressure generation associated with the heart. This forces
other anatomical segments of the heart to overcompensate leading to chronic ischemic
cardiomyopathy and congestive heart failure. Stem cell therapies have been extensively
researched in order to promote regeneration of cardiac tissue, but have several challenges such as
cell homing, retention and appropriate differentiation to cardiac muscle. Nanotechnology is a
novel approach that may assist in the delivery and tissue retention of stem cells. Despite
significant advances in the clinical treatment and prevention of AMI, this sort of
nanotechnology-based stem cell therapy has not yet been performed in vivo and over 370,000
Americans still die from CAD each year2.
Before nanotechnology is used in vivo, there is a need to address issues like opsonization,
phagocytosis by macrophages, and sequestration to the liver and spleen for eventual elimination
from the body6. Information in this regard would help to determine the gold nanoparticle’s
longevity in circulation and clearance rate from the body. The fates of these nanoparticles
depend heavily on their physio-biochemical properties, including their size, shape, and surface
chemistry. Novel approaches have reported to alter the surface chemistry of nanoparticles to
obtain desirable functionality allowing for greater blood circulation times as well as increased
biocompatibility7.
Since the functionality of nanoparticles in vivo is still under scrutiny, tagging conjugated
gold nanoparticles with a fluorophore can allow researchers to locate and image these particles
under ultra violet (UV) light. The fluorophore used in this study, FITC has an excitation
maximum at 490 nm and an emission maximum at 525 nm with a high quantum yield of 0.9310.
The quantum yield of a fluorophore is the number of photons emitted per photon absorbed. In
other words it is a measure of efficiency 0.0 being completely inefficient and 1.0 being
maximally efficient. Greater quantum yields are more desirable as they are stronger fluorescents
and are easier to image using fluorescent imaging techniques.
The objective of this study is to conjugate citrate gold nanoparticles with a fluorescent
antibody, FITC-IgG, and show successful conjugation and fluorescence. Successful completion
of this will allow further applications of stem cell therapy for treatment of myocardial infarctions
through nanotechnology.

5

Materials and Methods
Preparation of Citrate Au Nanoparticles:
15 nm diameter Au particles were prepared by citrate reduction of HAuCl4. Images were
then captured using a Transmission electron microscope (TEM) to observe the nanoparticles and
determine the size and dispersity. TEM image is shown in Figure 3.

Figure 3 TEM image of citrate Au nanoparticles.

A spectrophotometer was used to measure the absorbance of the gold nanoparticles are
various wavelengths to confirm particle identity. 1mL of the citrate gold solution (0.1mg/mL)
was centrifuged at 11,000 revolutions per minute (RPM) for 15 minutes. The supernatant was
removed and 100 µL of K-PBS was added. This tube was labeled A. The optical density was
obtained of tube A. The absorbance spectrum is shown in Figure 4.
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Figure 4. The absorbance spectrum of citrate gold nanoparticles shows an emission peak at 519nm.

Conjugation of Au Nanoparticles with FITC-IgG:
40 µL of FITC-IgG was added to 60 µL of K-PBS and was labeled B. The absorbance
spectrum of tube B was obtained and images of tube B under UV light was captured. The
fluorescence of tube A and tube B were measured with the fluorospectrometer and is shown in
Figure 7. The 1 mL contents of tube B was added dropwise into tube A while it was vortexed.
This solution contained both the Au nanoparticles and the FITC-IgG molecules and was labeled
tube C. The mixture was incubated at room temperature without shaking for 10 minutes. The
contents of tube C were placed in the fluorospectrometer to obtain its fluorescence spectra.
Images of tube C were taken next to tube A under UV light.
Washing of Unreacted Molecules:
The mixture was then centrifuged at 11,000 RPM for 15 minutes. The supernatant was
then removed and the optical density of the supernatant solution was measured using the
spectrophotometer. 1 mL of potassium phosphate-buffered saline (K-PBS) containing bovine
serum albumin (BSA) was added and mixed. This mixture was centrifuged at 11,000 RPM for 15
minutes and the supernatant was removed. Another 1 mL of K-PBS containing BSA was added
and then centrifuged at 11,000 RPM for 15 minutes removing the resulting supernatant. 200 µL
of K-PBS (pH 8.2, 2mM) was added to the tube and mixed. The optical density and fluorescence
of this resulting solution was measured.
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Calculations
The optical density of the supernatant unreacted mixture of FITC-IgG and AuNPs was measured
and subtracted from the optical density of FITC-IgG alone.
0.624 − 0.227 = 0.397
This gives the optical density of bound FITC-IgG molecules which proportionally corresponds
to a mass. The mass of FITC-IgG alone was 0.06mg. So the mass of bound FITC-IgG is
proportional based on the absorbance.
0.624
0.06 𝑚𝑔
=
0.397
𝑥
x = 0.03817 mg bound FITC-IgG
The mass can be converted to a number of moles using the molecular weight of IgG, 150 kg.
0.03817 𝑚𝑔
1𝑔
1 𝑘𝑔 1 𝑚𝑜𝑙 𝐼𝑔𝐺
∗
∗
= 2.5467 ∗ 10−10 𝑚𝑜𝑙 𝐼𝑔𝐺
1
1000 𝑚𝑔 1000 𝑔 150 𝑘𝑔
The number of moles can then be converted to a number of particles using Avogadro’s number.
2.5467 ∗ 10−10 𝑚𝑜𝑙 𝐼𝑔𝐺 6.023 ∗ 1023 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠
∗
= 1.5339 ∗ 1014 𝐼𝑔𝐺 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠
1
1 𝑚𝑜𝑙
The ratio of FITC-IgG particles to the number of AuNPs particles in solution, gives an
approximation of FITC-IgG molecules bound per nanoparticle.
1.5339 ∗ 1014 𝐼𝑔𝐺 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠
≈ 𝟐𝟒 𝑰𝒈𝑮 𝒎𝒐𝒍𝒆𝒄𝒖𝒍𝒆𝒔 𝒃𝒐𝒖𝒏𝒅 𝒑𝒆𝒓 𝑨𝒖𝑵𝑷
6.37 ∗ 1012 𝐴𝑢𝑁𝑃𝑠
There are approximately 24 FITC-IgG molecules bound per AuNP.
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Results
The absorbance spectrum of the citrate-AuNPs was compared to the FITC-IgG
conjugated citrate-AuNPs and is shown in Figure 5. A noticeable red-shift was detected once the
antibodies were bound to the nanoparticles. There was also a slight broadening of the extinction
peak.
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Figure 5 Spectrophotometer: After FITC-IgG conjugation of AuNPs, a slight red-shift was observed and a noticeable
broadening of the absorbance peak. This is an indication of successful conjugation. Absorbance increased at 280nm
indicating the presence of proteins.

In addition, the line for the conjugated AuNPs showed an absorbance peak at 280 nm, which is
the same wavelength at which proteins have peak absorbance15.
Images of FITC-IgG, unwashed conjugated AuNPs, and washed conjugated AuNPs were
captured under UV light and were compared in Figure 6. Image A, showed a very strong
fluorescence. Image B still showed a strong fluorescence but quenched. After washing away
unreacted molecules from the tube from image B the fluorescence was further reduced.
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Figure 6 UV Light: Image A compares fluorescence of AuNPs to FITC-IgG. Image B compares AuNPs to FITC-IgG + AuNPs.
Image C compares AuNPs to conjugated AuNPs.

A comparison of the relative fluorescence for the AuNPs, FITC-IgG, and the unwashed
reaction mixture is shown in Figure 7. This data is consistent with the UV light images from
Figure 6. Once the nanoparticles are mixed with the fluorescent antibodies, the magnitude of the
fluorescence decreased almost six-fold.
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Figure 7 Fluorospectrometer: Relative fluorescence measurements were obtained for each substrate and product.
Fluorescence was quenched for the reaction mixture.
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After washing the mixture, the fluorescence spectrum in Figure 8 showed further
quenching of the fluorescence. However, a fluorescence signal still exists.
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Figure 8 Fluorescence is further reduced after washing unreacted molecules

The BIO-RAD Gel Doc system was used to conduct a fluorescence test comparing the signal
from the citrate-AuNPs mixture and the conjugated FITC-IgG AuNPs. Figure 9 below compares
the image of the slide before and after placing it into the Gel Doc system. A signal containing no
fluorescence will show no color and a signal containing fluorescence will show up white. The
images in Figure 9 outline a faint fluorescent signal from the conjugated nanoparticle. This
information is consistent with the fluorospectrometer readings.
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Figure 9 Dot Test: Using the BIO-RAD Gel Doc system, a fluorescent detection test was conducted to
further investigate fluorescent properties of the conjugated AuNPs. (A) Citrate AuNPs control, (B)
Conjugated AuNPs.

To complete our data acquisition, images were taken using a Leica Confocal Microscope SP5II.
The advantage of using a laser scanning confocal microscope is reduced blurriness of images due
to light scattering, increased resolution and an improved signal-to-noise ratio through the use of a
pinhole at the confocal plane of the lens that serves to eliminate out of focus light16. For the
image shown in Figure 10 four laser wavelengths were used for excitation at a power level of
approximately 5%; 488 nm, 496 nm, 514 nm, 633 nm. The maximum emission wavelength range
for FITC is 520 nm to 530 nm12. The confocal images showed a significant number of small
particles that fluoresced with some being larger and stronger than others.
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Figure 10 Confocal Microscopy: The confocal image of the final conjugated product indisputably revealed several fluorescent
nanoparticles to conclude the investigation.

Discussion & Future Directions
The spectrophotometer readings in Figure 5 were an indication of molecule adsorption to
the surface of the AuNPs due to a change in refractive index of the surrounding solution9. There
was also a slight broadening of the extinction peak which occurs with particles of greater size.
Since proteins generally have the greatest absorbance at 280 nm, we can conclude that the
conjugated particles contained antibodies. The fluorospectrometer readings in Figure 7 showed
us that the addition of the fluorescent antibodies to the AuNPs solution is reducing the
fluorescence to one that is in between that of the two individual components. Furthermore,
assuming all unreacted FITC-IgG molecules were removed, the signal of the unwashed mixture
from Figure 8 may have been from the free flowing FITC-IgG. Thus, the washed mixture
showed a signal characteristic of the conjugated nanoparticles only. This must mean that the sole
binding of the FITC-IgG to the AuNPs is resulting in a quenched fluorescence of the
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fluorophore.It may be possible that unreacted FITC-IgG molecules remained in solution after
being washed. We would expect these molecules to fluoresce equally. The confocal microscope
image in Figure 10 shows some stronger than others which may allow us to be certain to some
degree that the lower intensity fluorescent particles are those that are conjugated to the gold
nanoparticles and thus quenched.
The spectrophotometer readings were strong indications that conjugation of gold
nanoparticles with the fluorescent antibodies was successful. However, a significant amount of
quenching of the fluorescence was evident from the various fluorescence detection tests.
Fluorescence can be quenched due to the nanoparticle’s plasmon field strength. As the distance
of the fluorescent agent increases from the nanoparticle’s surface, the field strength decreases
and the effects of quenching are significantly reduced13. To combat this issue a linker molecule
could be used to extend the fluorescent antibody away from the nanoparticle. This would allow
for the plasmon field strength to have a lesser electronic impact on the quenching of the
fluorescence. Other studies have suggested that having the nanoparticle’s absorbance peak in the
same region as the fluorophore’s emission peak could impact the ability for the fluorophore to be
fully expressed.
In this particular study, the directionality of the antibodies was not controlled; therefore
further imaging is required to confirm that the constant region was bound directly to the
nanoparticles14. For stem cell therapy to applicable the variable region to the antibody must be
exposed to attract and bind specific antigens. In addition, controlling the directionality of the
bound antibodies will allow scientists to predict how close the fluorophore is to the nanoparticle
surface and thus predicting the amount of fluorescent quenching.
The mechanisms used in this study involved non-covalent binding. Other methods of
binding could be employed for increased stability and directional orientation such as covalent
bonds involving free sulfhydryl groups14.
In conclusion, gold nanoparticles were successfully conjugated with fluorescent
antibodies, and the methodology for a subsequent stem cell study was developed and validated.
The ease of detection of nanoparticles is extremely important as we consider an in vivo study,
and thus quenching must be minimized. Prior to proceeding to experiments with stem cells, we
plan to test the utilization of a linker molecule, control the directionality of the antibodies, and
explore covalent bonding to improve nanoparticle fluorescence.
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